Share:
Peer-Reviewed Publication
Lancet Digit Health2026;8(6):101005.June 1, 2026Journal Article

Impracticality of banning collection of data on race and ethnicity in artificial intelligence-enabled health care in France.

Benjamin C Guinhouya1, Thomas Morgenroth2, Fabio Boudis3, Geoffroy K Apété4, Gloria T Dossou5, Gilles Gasso6, Djamel Zitouni7
1University of Lille, Inserm, CHU Lille, U1366, Cancer Research Center of Lille (CRC Lille), F-59000 Lille, France; UFR 3S - ILIS, University of Lille, F-59000 Lille, France. Electronic address: benjamin.guinhouya@univ-lille.fr.
2University of Strasbourg, Faculty of Pharmacy, CEIE EA 7307, CNRS FR 3241, F-67401 Illkirch-Graffenstaden, France.
3UFR 3S - ILIS, University of Lille, F-59000 Lille, France; Department of Medical Information, CHU Lille, F-59000 Lille, France.
4UFR 3S - ILIS, University of Lille, F-59000 Lille, France.
5UFR 3S - ILIS, University of Lille, F-59000 Lille, France; University of Lille, ULR 4999 LUMEN, F-59000 Lille, France.
6University of Normandie, INSA Rouen Normandie, UNIROUEN, UNIHAVRE, Laboratoire d'Informatique, du Traitement de l'Information et des Systèmes (LITIS), F-76000 Rouen, France.
7University of Lille, Inserm, CHU Lille, U1366, Cancer Research Center of Lille (CRC Lille), F-59000 Lille, France; UFR 3S - Pharmacy, University of Lille, F-59000 Lille, France.

Abstract

Artificial intelligence (AI) or machine learning (ML) are revolutionising health care, enhancing diagnostics and treatment through AI-enabled medical devices. However, the effectiveness of AI or ML models is hindered by substantial biases, particularly against minority populations such as African and Afro-descendant people. In this Viewpoint, we discuss the colour-blind policy of France, which pro…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.